Agios Anticipates PK Deficiency Diagnosis Ramp-Up After Pyrukynd Approval

Reimbursement Challenges

 
• By Alaric DeArment
  
3-D Rendering Red Blood Cells
The FDA approved Agios' Pyrukynd for pyruvate kinase deficiency on 17 February • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip